Mindset Adds Medicinal Chemist to Scientific Advisory Team

December 1, 2019

Mindset Pharma Inc. (“Mindset” or the “Company”) is pleased to announce that it has engaged Slassi Consulting Services to provide the scientific advisory services of Mr. Malik Slassi on an immediate basis. Mr. Slassi is the founder, President and Chief Scientific Officer of Fluorinov Pharma Inc., which was acquired by Trillium in January 2016. With over 30 years of experience in the successful identification and development of small molecule drug candidates across multiple therapeutic areas, Mr. Slassi is uniquely positioned to assist Mindset Pharma with is business plans. Mr. Slassi is a former Director and Vice President of Medicinal Chemistry and Manufacturing Drug Development at NPS Pharmaceuticals and Cascade Therapeutics, respectively, and earlier he held management and scientific positions at Allelix Biopharmaceuticals Inc., Boehringer Ingelheim Research Inc. and Rhône Poulenc. During his career, Mr. Slassi has been involved in numerous multinational R&D collaborations including with Hoechst AG (Sanofi Aventis), AstraZeneca, Johnson Johnson, Forest Laboratories, GlaxoSmithKline, and Memory Pharmaceuticals. For seven years, Mr. Slassi served on the steering committee for the multinational collaboration on the metabotropic Glutamate Receptors mGluRs program between NPS Pharma and AstraZeneca. Mr. Richard Patricio, founder and Director of Mindset Pharma noted, “Mr. Slassi’s strong track record of drug development is unparalleled. He has had over 20 drug candidates advanced into late stage preclinical, clinical development and market. We are pleased to welcome him to the team.” Mr. Slassi holds a PhD in chemistry from the University of Claude Bernard, Lyon, France and completed his postdoctoral work in the Chemistry Department at the University of Montreal, Canada. He is a true inventor with over 130 issued and published patents and patent applications, and author of more than 65 scientific and review articles published in international peer reviewed journals

 

About Mindset Pharma

 

Mindset Pharma is a drug discovery business focused on creating novel and patentable psychedelic compounds for the treatment of neurological and psychiatric disorders. Founded by serial entrepreneurs and domain experts in drug development and medicinal chemistry and based in Toronto, Canada, Mindset is assembling a proprietary library of transformative psychedelic intellectual property designed to address chronic neuropsychiatric disorders efficiently and safely.

Mindset

Sign-up for company updates

Copyright © 2019 - All Rights Reserved by Mindset Pharma Inc.